These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

376 related items for PubMed ID: 14578760

  • 1. Impact of cytochrome p450 3A5 genetic polymorphism on tacrolimus doses and concentration-to-dose ratio in renal transplant recipients.
    Thervet E, Anglicheau D, King B, Schlageter MH, Cassinat B, Beaune P, Legendre C, Daly AK.
    Transplantation; 2003 Oct 27; 76(8):1233-5. PubMed ID: 14578760
    [Abstract] [Full Text] [Related]

  • 2. Influence of CYP3A5 genetic polymorphism on tacrolimus daily dose requirements and acute rejection in renal graft recipients.
    Quteineh L, Verstuyft C, Furlan V, Durrbach A, Letierce A, Ferlicot S, Taburet AM, Charpentier B, Becquemont L.
    Basic Clin Pharmacol Toxicol; 2008 Dec 27; 103(6):546-52. PubMed ID: 19067682
    [Abstract] [Full Text] [Related]

  • 3. Influence of CYP3A5 and MDR1 polymorphisms on tacrolimus concentration in the early stage after renal transplantation.
    Zhang X, Liu ZH, Zheng JM, Chen ZH, Tang Z, Chen JS, Li LS.
    Clin Transplant; 2005 Oct 27; 19(5):638-43. PubMed ID: 16146556
    [Abstract] [Full Text] [Related]

  • 4. Association between cyclosporine concentration and genetic polymorphisms of CYP3A5 and MDR1 during the early stage after renal transplantation.
    Azarpira N, Aghdaie MH, Behzad-Behbahanie A, Geramizadeh B, Behzadi S, Malekhoseinie SA, Raisjalal GH, Rahsaz M, Pourgholami A, Sagheb F.
    Exp Clin Transplant; 2006 Jun 27; 4(1):416-9. PubMed ID: 16827636
    [Abstract] [Full Text] [Related]

  • 5. Tacrolimus dosing in adult lung transplant patients is related to cytochrome P4503A5 gene polymorphism.
    Zheng H, Zeevi A, Schuetz E, Lamba J, McCurry K, Griffith BP, Webber S, Ristich J, Dauber J, Iacono A, Grgurich W, Zaldonis D, McDade K, Zhang J, Burckart GJ.
    J Clin Pharmacol; 2004 Feb 27; 44(2):135-40. PubMed ID: 14747421
    [Abstract] [Full Text] [Related]

  • 6. Tacrolimus dose requirement in relation to donor and recipient ABCB1 and CYP3A5 gene polymorphisms in Chinese liver transplant patients.
    Wei-lin W, Jing J, Shu-sen Z, Li-hua W, Ting-bo L, Song-feng Y, Sheng Y.
    Liver Transpl; 2006 May 27; 12(5):775-80. PubMed ID: 16628701
    [Abstract] [Full Text] [Related]

  • 7. CYP3A5 and MDR1 genetic polymorphisms and cyclosporine pharmacokinetics after renal transplantation.
    Anglicheau D, Thervet E, Etienne I, Hurault De Ligny B, Le Meur Y, Touchard G, Büchler M, Laurent-Puig P, Tregouet D, Beaune P, Daly A, Legendre C, Marquet P.
    Clin Pharmacol Ther; 2004 May 27; 75(5):422-33. PubMed ID: 15116055
    [Abstract] [Full Text] [Related]

  • 8. Impact of MDR1 and CYP3A5 on the oral clearance of tacrolimus and tacrolimus-related renal dysfunction in adult living-donor liver transplant patients.
    Fukudo M, Yano I, Yoshimura A, Masuda S, Uesugi M, Hosohata K, Katsura T, Ogura Y, Oike F, Takada Y, Uemoto S, Inui K.
    Pharmacogenet Genomics; 2008 May 27; 18(5):413-23. PubMed ID: 18408564
    [Abstract] [Full Text] [Related]

  • 9. The effect of CYP3A5 polymorphisms on the pharmacokinetics of tacrolimus in adolescent kidney transplant recipients.
    Tirelli S, Ferraresso M, Ghio L, Meregalli E, Martina V, Belingheri M, Mattiello C, Torresani E, Edefonti A.
    Med Sci Monit; 2008 May 27; 14(5):CR251-254. PubMed ID: 18443548
    [Abstract] [Full Text] [Related]

  • 10. Impact of CYP3A5 and MDR1(ABCB1) C3435T polymorphisms on the pharmacokinetics of tacrolimus in renal transplant recipients.
    Tada H, Tsuchiya N, Satoh S, Kagaya H, Li Z, Sato K, Miura M, Suzuki T, Kato T, Habuchi T.
    Transplant Proc; 2005 May 27; 37(4):1730-2. PubMed ID: 15919447
    [Abstract] [Full Text] [Related]

  • 11. Genetic polymorphisms of CYP3A5 genes and concentration of the cyclosporine and tacrolimus.
    Zhao Y, Song M, Guan D, Bi S, Meng J, Li Q, Wang W.
    Transplant Proc; 2005 May 27; 37(1):178-81. PubMed ID: 15808586
    [Abstract] [Full Text] [Related]

  • 12. Significant impact of gene polymorphisms on tacrolimus but not cyclosporine dosing in Asian renal transplant recipients.
    Loh PT, Lou HX, Zhao Y, Chin YM, Vathsala A.
    Transplant Proc; 2008 Jun 27; 40(5):1690-5. PubMed ID: 18589174
    [Abstract] [Full Text] [Related]

  • 13. Influence of the CYP3A5 genotype on tacrolimus pharmacokinetics and pharmacodynamics in young kidney transplant recipients.
    Ferraresso M, Tirelli A, Ghio L, Grillo P, Martina V, Torresani E, Edefonti A.
    Pediatr Transplant; 2007 May 27; 11(3):296-300. PubMed ID: 17430486
    [Abstract] [Full Text] [Related]

  • 14. Effect of CYP3A5 genotype on renal allograft recipients treated with tacrolimus.
    Chen JS, Li LS, Cheng DR, Ji SM, Sun QQ, Cheng Z, Wen JQ, Sha GZ, Liu ZH.
    Transplant Proc; 2009 Jun 27; 41(5):1557-61. PubMed ID: 19545678
    [Abstract] [Full Text] [Related]

  • 15. Clinical relevance and prevalence of polymorphisms in CYP3A5 and MDR1 genes that encode tacrolimus biotransformation enzymes in liver transplant recipients.
    Barrera-Pulido L, Aguilera-García I, Docobo-Pérez F, Alamo-Martínez JM, Pareja-Ciuró F, Nuñez-Roldán A, Gómez-Bravo MA, Bernardos-Rodríguez A.
    Transplant Proc; 2008 Nov 27; 40(9):2949-51. PubMed ID: 19010156
    [Abstract] [Full Text] [Related]

  • 16. Individualization of tacrolimus dosage basing on cytochrome P450 3A5 polymorphism--a prospective, randomized, controlled study.
    Chen SY, Li JL, Meng FH, Wang XD, Liu T, Li J, Liu LS, Fu Q, Huang M, Wang CX.
    Clin Transplant; 2013 Nov 27; 27(3):E272-81. PubMed ID: 23432535
    [Abstract] [Full Text] [Related]

  • 17. Pharmacogenetics of immunosuppressant polymorphism of CYP3A5 in renal transplant recipients.
    Larriba J, Imperiali N, Groppa R, Giordani C, Algranatti S, Redal MA.
    Transplant Proc; 2010 Nov 27; 42(1):257-9. PubMed ID: 20172323
    [Abstract] [Full Text] [Related]

  • 18. Influence of CYP3A5 and MDR1 (ABCB1) polymorphisms on the pharmacokinetics of tacrolimus in renal transplant recipients.
    Tsuchiya N, Satoh S, Tada H, Li Z, Ohyama C, Sato K, Suzuki T, Habuchi T, Kato T.
    Transplantation; 2004 Oct 27; 78(8):1182-7. PubMed ID: 15502717
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.